DOI QR코드

DOI QR Code

Effect of intraperitoneally administered propentofylline in a rat model of postoperative pain

  • Choi, Geun Joo (Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine) ;
  • Kang, Hyun (Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine) ;
  • Lee, Jun Mo (Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine) ;
  • Baek, Chong Wha (Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine) ;
  • Jung, Yong Hun (Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine) ;
  • Woo, Young Cheol (Department of Anesthesiology and Pain Medicine, Chung-Ang University College of Medicine) ;
  • Do, Jae Hyuk (Department of Internal Medicine, Chung-Ang University College of Medicine) ;
  • Ko, Jin Soo (Department of Plastic Surgery, National Police Hospital)
  • Received : 2020.07.08
  • Accepted : 2020.08.09
  • Published : 2020.09.30

Abstract

Background: In this study, we sought to evaluate whether systemic propentofylline (PPF) has antiallodynic effects in a rat model of postoperative pain, and to assess the mechanism involved. Methods: After plantar incision, rats were intraperitoneally injected with various doses of PPF to evaluate its antiallodynic effect. To investigate the involved mechanism, rats were intraperitoneally injected with yohimbine, dexmedetomidine, prazosin, naloxone, atropine or mecamylamine, following the incision of the rat hind paws, and then PPF was administered intraperitoneally. The mechanical withdrawal threshold (MWT) was evaluated using von Frey filaments at various time points and serum levels of tumor necrosis factor (TNF)-α, interleukin (IL)-1β, and IL-6 were measured to determine the inflammatory response level. Results: MWT was significantly increased after intraperitoneal injection of 30 mg/kg of PPF when compared with the control group. Injection of PPF and yohimbine, atropine or mecamylamine showed significant decreases in the MWT, while injection of PPF and dexmedetomidine showed a significant increase. Systemic administration of PPF inhibited the post-incisional increase in serum level of TNF-α and IL-1β. Conclusions: Systemic administration of PPF following surgery presented antiallodynic effects in a rat model of postoperative pain. The antiallodynic effects against mechanical allodynia could be mediated by α-adrenergic and cholinergic receptors.

Keywords

References

  1. Apfelbaum JL, Chen C, Mehta SS, Gan TJ. Postoperative pain experience: results from a national survey suggest postoperative pain continues to be undermanaged. Anesth Analg 2003; 97: 534-40. https://doi.org/10.1213/01.ANE.0000068822.10113.9E
  2. Gan TJ, Habib AS, Miller TE, White W, Apfelbaum JL. Incidence, patient satisfaction, and perceptions of post-surgical pain: results from a US national survey. Curr Med Res Opin 2014; 30: 149-60. https://doi.org/10.1185/03007995.2013.860019
  3. Chou R, Gordon DB, de Leon-Casasola OA, Rosenberg JM, Bickler S, Brennan T, et al. Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists' Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain 2016; 17: 131-57. https://doi.org/10.1016/j.jpain.2015.12.008
  4. Sweitzer S, De Leo J. Propentofylline: glial modulation, neuroprotection, and alleviation of chronic pain. Handb Exp Pharmacol 2011; (200): 235-50.
  5. Raghavendra V, Tanga F, Rutkowski MD, DeLeo JA. Antihyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain 2003; 104: 655-64. https://doi.org/10.1016/S0304-3959(03)00138-6
  6. Tawfik VL, Regan MR, Haenggeli C, Lacroix-Fralish ML, Nutile-McMenemy N, Perez N, et al. Propentofyllineinduced astrocyte modulation leads to alterations in glial glutamate promoter activation following spinal nerve transection. Neuroscience 2008; 152: 1086-92. https://doi.org/10.1016/j.neuroscience.2008.01.065
  7. Ellis A, Wieseler J, Favret J, Johnson KW, Rice KC, Maier SF, et al. Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain. J Pain 2014; 15: 407-21. https://doi.org/10.1016/j.jpain.2013.12.007
  8. Gwak YS, Crown ED, Unabia GC, Hulsebosch CE. Propentofylline attenuates allodynia, glial activation and modulates GABAergic tone after spinal cord injury in the rat. Pain 2008; 138: 410-22. https://doi.org/10.1016/j.pain.2008.01.021
  9. Zhang J, Wu D, Xie C, Wang H, Wang W, Zhang H, et al. Tramadol and propentofylline coadministration exerted synergistic effects on rat spinal nerve ligation-induced neuropathic pain. PLoS One 2013; 8: e72943. https://doi.org/10.1371/journal.pone.0072943
  10. Brennan TJ, Vandermeulen EP, Gebhart GF. Characterization of a rat model of incisional pain. Pain 1996; 64: 493-501. https://doi.org/10.1016/0304-3959(95)01441-1
  11. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412. https://doi.org/10.1371/journal.pbio.1000412
  12. Sluka KA, Kalra A, Moore SA. Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia. Muscle Nerve 2001; 24: 37-46. https://doi.org/10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8
  13. Kim TK, Kim YS, Yoon JR, Han IS, Kim JS, Lee CW. The effect of an intraperitoneal injection of ketamine and ketorolac on mechanical allodynia in rats with spinal nerve ligation. Korean J Anesthesiol 2004; 46: 719-23. https://doi.org/10.4097/kjae.2004.46.6.719
  14. Macrae WA. Chronic pain after surgery. Br J Anaesth 2001; 87: 88-98. https://doi.org/10.1093/bja/87.1.88
  15. Sweitzer SM, Schubert P, DeLeo JA. Propentofylline, a glial modulating agent, exhibits antiallodynic properties in a rat model of neuropathic pain. J Pharmacol Exp Ther 2001; 297: 1210-7.
  16. Jung S, Donhauser T, Toyka KV, Hartung HP. Propentofylline and iloprost suppress the production of TNF-alpha by macrophages but fail to ameliorate experimental autoimmune encephalomyelitis in Lewis rats. J Autoimmun 1997; 10: 519-29. https://doi.org/10.1006/jaut.1997.0159
  17. Sommer C, Kress M. Recent findings on how proinflammatory cytokines cause pain: peripheral mechanisms in inflammatory and neuropathic hyperalgesia. Neurosci Lett 2004; 361: 184-7. https://doi.org/10.1016/j.neulet.2003.12.007
  18. Watkins LR, Maier SF, Goehler LE. Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states. Pain 1995; 63: 289-302. https://doi.org/10.1016/0304-3959(95)00186-7
  19. Colburn RW, DeLeo JA, Rickman AJ, Yeager MP, Kwon P, Hickey WF. Dissociation of microglial activation and neuropathic pain behaviors following peripheral nerve injury in the rat. J Neuroimmunol 1997; 79: 163-75. https://doi.org/10.1016/S0165-5728(97)00119-7
  20. Schubert P, Morino T, Miyazaki H, Ogata T, Nakamura Y, Marchini C, et al. Cascading glia reactions: a common pathomechanism and its differentiated control by cyclic nucleotide signaling. Ann N Y Acad Sci 2000; 903: 24-33. https://doi.org/10.1111/j.1749-6632.2000.tb06346.x
  21. Schubert P, Ogata T, Rudolphi K, Marchini C, McRae A, Ferroni S. Support of homeostatic glial cell signaling: a novel therapeutic approach by propentofylline. Ann N Y Acad Sci 1997; 826: 337-47. https://doi.org/10.1111/j.1749-6632.1997.tb48484.x
  22. Clark IA. How TNF was recognized as a key mechanism of disease. Cytokine Growth Factor Rev 2007; 18: 335-43. https://doi.org/10.1016/j.cytogfr.2007.04.002
  23. Luo G, Hershko DD, Robb BW, Wray CJ, Hasselgren PO. IL-1beta stimulates IL-6 production in cultured skeletal muscle cells through activation of MAP kinase signaling pathway and NF-kappa B. Am J Physiol Regul Integr Comp Physiol 2003; 284: R1249-54. https://doi.org/10.1152/ajpregu.00490.2002
  24. Crassous PA, Denis C, Paris H, Senard JM. Interest of alpha2-adrenergic agonists and antagonists in clinical practice: background, facts and perspectives. Curr Top Med Chem 2007; 7: 187-94. https://doi.org/10.2174/156802607779318190
  25. Lavand'homme PM, Eisenach JC. Perioperative administration of the alpha2-adrenoceptor agonist clonidine at the site of nerve injury reduces the development of mechanical hypersensitivity and modulates local cytokine expression. Pain 2003; 105: 247-54. https://doi.org/10.1016/S0304-3959(03)00221-5
  26. Schechtmann G, Song Z, Ultenius C, Meyerson BA, Linderoth B. Cholinergic mechanisms involved in the pain relieving effect of spinal cord stimulation in a model of neuropathy. Pain 2008; 139: 136-45. https://doi.org/10.1016/j.pain.2008.03.023
  27. Jessen Lundorf L, Korvenius Nedergaard H, Moller AM. Perioperative dexmedetomidine for acute pain after abdominal surgery in adults. Cochrane Database Syst Rev 2016; 2: CD010358.
  28. Boyer KC, McDonald P, Zoetis T. A novel formulation of ketorolac tromethamine for intranasal administration: preclinical safety evaluation. Int J Toxicol 2010; 29: 467-78. https://doi.org/10.1177/1091581810374372
  29. Chellman GJ, Lollini LO, Dorr AE, DePass LR. Comparison of ketorolac tromethamine with other injectable nonsteroidal anti-inflammatory drugs for pain-on-injection and muscle damage in the rat. Hum Exp Toxicol 1994; 13: 111-7. https://doi.org/10.1177/096032719401300209
  30. Malmberg AB, Yaksh TL. Antinociceptive actions of spinal nonsteroidal anti-inflammatory agents on the formalin test in the rat. J Pharmacol Exp Ther 1992; 263: 136-46.